Staffa J - Search Results

1

Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis.

McAdams M, Staffa J, Dal Pan G. McAdams M, et al. Among authors: staffa j. Pharmacoepidemiol Drug Saf. 2008 Mar;17(3):229-39. doi: 10.1002/pds.1535. Pharmacoepidemiol Drug Saf. 2008. PMID: 18175291

2

Duration of therapy with metoclopramide: a prescription claims data study.

Kaplan S, Staffa JA, Dal Pan GJ. Kaplan S, et al. Among authors: staffa ja. Pharmacoepidemiol Drug Saf. 2007 Aug;16(8):878-81. doi: 10.1002/pds.1397. Pharmacoepidemiol Drug Saf. 2007. PMID: 17436356

3

Onset of acute myocardial infarction after use of non-steroidal anti-inflammatory drugs.

Hammad TA, Graham DJ, Staffa JA, Kornegay CJ, Dal Pan GJ. Hammad TA, et al. Among authors: staffa ja. Pharmacoepidemiol Drug Saf. 2008 Apr;17(4):315-21. doi: 10.1002/pds.1560. Pharmacoepidemiol Drug Saf. 2008. PMID: 18302311

4

Measures to quantify the abuse of prescription opioids: a review of data sources and metrics.

Secora AM, Dormitzer CM, Staffa JA, Dal Pan GJ. Secora AM, et al. Among authors: staffa ja. Pharmacoepidemiol Drug Saf. 2014 Dec;23(12):1227-37. doi: 10.1002/pds.3711. Epub 2014 Sep 25. Pharmacoepidemiol Drug Saf. 2014. PMID: 25257660 Review.

5

Regulatory innovation in postmarketing risk assessment and management.

Staffa JA, Dal Pan GJ. Staffa JA, et al. Clin Pharmacol Ther. 2012 Mar;91(3):555-7. doi: 10.1038/clpt.2011.289. Epub 2012 Feb 1. Clin Pharmacol Ther. 2012. PMID: 22297386

6

The concomitant prescribing of ethinyl estradiol/drospirenone and potentially interacting drugs.

McAdams M, Staffa JA, Dal Pan GJ. McAdams M, et al. Among authors: staffa ja. Contraception. 2007 Oct;76(4):278-81. doi: 10.1016/j.contraception.2007.06.002. Epub 2007 Aug 1. Contraception. 2007. PMID: 17900437

7

Patterns of opioid analgesic use in the U.S., 2009 to 2018.

Woods C, Chai G, Meyer T, Staffa J, Dal Pan G. Woods C, et al. Among authors: staffa j. Pain. 2021 Apr 1;162(4):1060-1067. doi: 10.1097/j.pain.0000000000002101. Pain. 2021. PMID: 33021566

8

The future of population-based postmarket drug risk assessment: a regulator's perspective.

Hammad TA, Neyarapally GA, Iyasu S, Staffa JA, Dal Pan G. Hammad TA, et al. Among authors: staffa ja. Clin Pharmacol Ther. 2013 Sep;94(3):349-58. doi: 10.1038/clpt.2013.118. Epub 2013 Jun 5. Clin Pharmacol Ther. 2013. PMID: 23739537

9

Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy.

Chang JT, Staffa JA, Parks M, Green L. Chang JT, et al. Pharmacoepidemiol Drug Saf. 2004 Jul;13(7):417-26. doi: 10.1002/pds.977. Pharmacoepidemiol Drug Saf. 2004. PMID: 15269925

10

Risk factors for statin-associated rhabdomyolysis.

Schech S, Graham D, Staffa J, Andrade SE, La Grenade L, Burgess M, Blough D, Stergachis A, Chan KA, Platt R, Shatin D. Schech S, et al. Among authors: staffa j. Pharmacoepidemiol Drug Saf. 2007 Mar;16(3):352-8. doi: 10.1002/pds.1287. Pharmacoepidemiol Drug Saf. 2007. PMID: 16892458

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters